We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    silenseed
Previous Study | Return to List | Next Study

A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer (PROTACT)

This study is not yet open for participant recruitment.
Verified November 2017 by Silenseed Ltd
Sponsor:
ClinicalTrials.gov Identifier:
NCT01676259
First Posted: August 30, 2012
Last Update Posted: November 16, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Silenseed Ltd
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: June 2020
  Estimated Primary Completion Date: November 2019 (Final data collection date for primary outcome measure)